← FDA DRUG APPROVALS

FDA ANDA · ANDA073141

IBUPROFEN

Sponsor: TEVA

APPLICATION
ANDA073141
TYPE
ANDA
ORIGINAL APPROVAL
1992-05-29
LATEST ACTION
1999-12-02
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

IBUPROFENDiscontinued
IBUPROFEN 200MG · TABLET · ORAL

Approval history

1999-12-02Manufacturing (CMC) · Supplement 8AP
1999-12-02Manufacturing (CMC) · Supplement 9AP
1999-02-12Manufacturing (CMC) · Supplement 2AP
1999-02-12Manufacturing (CMC) · Supplement 3AP
1998-08-28Manufacturing (CMC) · Supplement 1AP
1992-05-29OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →